LPC
MIRM icon

Lion Point Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Lion Point Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,500
Closed -$371K – 35
2023
Q4 		$399K Sell
13,500
-13,500
-50% -$409K 0.2% 22
2023
Q3 		$853K Hold
27,000
– – 0.38% 16
2023
Q2 		$698K Sell
27,000
-70,000
-72% -$1.86M 0.32% 21
2023
Q1 		$2.33M Hold
97,000
– – 0.96% 15
2022
Q4 		$2.07M Buy
97,000
+17,000
+21% +$336K 0.29% 24
2022
Q3 		$1.72M Buy
+80,000
New +$1.93M 0.38% 31

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return